electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the[...]
11/20/2024 | Press release | Distributed by Public on 11/20/2024 07:15
Please select the service you want to use:
Smartlinks | Ocugen Inc. | News | Health | Biotechnology | Technology | Biotechnology | Science | Biotechnology | Research | Company News | Business Announcement | Products and Services | Securities Issuers | Biotechnology and Medical Research Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | Bulgarian Stock Exchange | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Bolsa Institucional de Valores (BIVA) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact